UG

United-Guardian IncNASDAQ UG Stock Report

Last reporting period 30 Jun, 2024

Updated 30 Oct, 2024

Last price

Market cap $B

0.072

Micro

Exchange

XNAS - Nasdaq

UG Stock Analysis

UG

Neutral

Based on Eyestock quantitative analysis, UG`s fundamental data and valuation indicate an investment grade of Neutral at the current time.

Rating

To assess the quality of a company's business, we have collected all financial data from the statements and presented them in the form of a single number - the company's rating. Rating value of 100 is the threshold for determining a viable investment.

126/100

High score

Upside

To determine whether the current price is a reasonable to buy a stock, we compare it to our estimate of fair value. The more undervalued a stock is, the higher the upside.

-10.4 %

Overvalued

Market cap $B

0.072

Dividend yield

5.61 %

Shares outstanding

4.594 B

United-Guardian, Inc. develops and manufactures pharmaceuticals, cosmetic ingredients, personal and health care products and medical devices. The company is headquartered in Hauppauge, New York. Its cosmetic ingredients include Lubrajel PF, Lubrajel Oil PF, Lubrajel II XD PF, Lubrajel Natural, Lubrajel Marine, Lubrajel II XD, Lubrasil II SB, B-122, Klensoft and Orchid Complex. Its medical lubricants include Lubrajel RR and RC, Lubrajel MG, Lubrajel LC and Lubrajel FA, and Lubrajel Fluid. Its pharmaceuticals products include Renacidin, which is a prescription drug product that is used to prevent and to dissolve calcifications in urethral catheters, and in the urinary bladder, and Clorpactin WCS90, which is an antimicrobial product used in urology to treat infections in the urinary bladder. Its industrial products consist of Deselex, which is a sequestering and chelating agent that is used as a replacement for phosphates in the manufacture of detergents, and Thoroclens, which is a chlorine-based industrial cleanser.

View Section: Eyestock Rating